4-Androsten-4-ol-3,17-dione acetate

Modify Date: 2025-08-26 13:36:12

4-Androsten-4-ol-3,17-dione acetate Structure
4-Androsten-4-ol-3,17-dione acetate structure
Common Name 4-Androsten-4-ol-3,17-dione acetate
CAS Number 61630-32-8 Molecular Weight 344.44500
Density 1.18g/cm3 Boiling Point 501.2ºC at 760 mmHg
Molecular Formula C21H28O4 Melting Point N/A
MSDS Chinese USA Flash Point 219.2ºC

 Names

Name 4-Androsten-4-ol-3,17-dione acetate
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.18g/cm3
Boiling Point 501.2ºC at 760 mmHg
Molecular Formula C21H28O4
Molecular Weight 344.44500
Flash Point 219.2ºC
Exact Mass 344.19900
PSA 60.44000
LogP 3.97820
Index of Refraction 1.548
InChIKey LRXSFNGKRCOHRS-VMRCMBGLSA-N
SMILES CC(=O)OC1=C2CCC3C4CCC(=O)C4(C)CCC3C2(C)CCC1=O

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
BV8153000
CHEMICAL NAME :
Androst-4-ene-3,17-dione, 4-hydroxy-, acetate (ester)
CAS REGISTRY NUMBER :
61630-32-8
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C21-H28-O4
MOLECULAR WEIGHT :
344.49

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
300 mg/kg
SEX/DURATION :
female 2-7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)
REFERENCE :
BIREBV Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- Volume(issue)/page/year: 18,365,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Implant
DOSE :
375 mg/kg
SEX/DURATION :
female 18 day(s) pre-mating female 1-8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - mating performance (e.g. # sperm positive females per # females mated; # copulations per # estrus cycles)
REFERENCE :
BIREBV Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- Volume(issue)/page/year: 18,365,1978

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport
RTECS BV8153000

 Synthetic Route

~97%

4-Androsten-4-ol-3,17-dione acetate Structure

4-Androsten-4-o...

CAS#:61630-32-8

Literature: Andrade; Paixao; De Almeida; Fernandes Roleira; Tavares Da Silva Acta Crystallographica Section C: Crystal Structure Communications, 2007 , vol. 63, # 6 p. o330-o331

~66%

4-Androsten-4-ol-3,17-dione acetate Structure

4-Androsten-4-o...

CAS#:61630-32-8

Literature: Marsh, David A.; Brodie, Harry J.; Garrett, Wesley; Tsai-Morris, Chon-Hwa; Brodie, Angela M. H. Journal of Medicinal Chemistry, 1985 , vol. 28, # 6 p. 788 - 795

~%

4-Androsten-4-ol-3,17-dione acetate Structure

4-Androsten-4-o...

CAS#:61630-32-8

Literature: Mann, John; Pietrzak, Barbara Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , # 11 p. 2681 - 2685

~%

4-Androsten-4-ol-3,17-dione acetate Structure

4-Androsten-4-o...

CAS#:61630-32-8

Literature: Varela, Carla; Tavares Da Silva, Elisiario J.; Amaral, Cristina; Correia Da Silva, Georgina; Baptista, Teresa; Alcaro, Stefano; Costa, Giosue; Carvalho, Rui A.; Teixeira, Natercia A. A.; Roleira, Fernanda M. F. Journal of Medicinal Chemistry, 2012 , vol. 55, # 8 p. 3992 - 4002

~%

4-Androsten-4-ol-3,17-dione acetate Structure

4-Androsten-4-o...

CAS#:61630-32-8

Literature: Mann, John; Pietrzak, Barbara Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , # 11 p. 2681 - 2685

 Articles14

More Articles
Aromatase inhibitors and the treatment of breast cancer.

J. Steroid Biochem. 24 , 91, (1986)

Inhibition of aromatase to reduce estrogen production by peripheral and ovarian tissue could be a useful approach to treating hormone-dependent breast cancer. Several C19, 17 keto steroids have been i...

Inhibition of estrogen biosynthesis and regression of mammary tumors by aromatase inhibitors.

Adv. Exp. Med. Biol. 138 , 179-90, (1981)

Overview of recent development of aromatase inhibitors.

Cancer Res. 42(8 Suppl) , 3312s-3314s, (1982)

Since the first publication in 1973 concerning aromatase inhibitors, several effective compounds have been reported by a number of investigators. Our studies with 4-hydroxyandrostene-3,17-dione, 4-ace...

 Synonyms

[(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here